Boosting Anti-Inflammatory Potency of Zafirlukast by Designed Polypharmacology.
J Med Chem
; 61(13): 5758-5764, 2018 07 12.
Article
in En
| MEDLINE
| ID: mdl-29878767
ABSTRACT
Multitarget design offers access to bioactive small molecules with potentially superior efficacy and safety. Particularly multifactorial chronic inflammatory diseases demand multiple pharmacological interventions for stable treatment. By minor structural changes, we have developed a close analogue of the cysteinyl-leukotriene receptor antagonist zafirlukast that simultaneously inhibits soluble epoxide hydrolase and activates peroxisome proliferator-activated receptor γ. The triple modulator exhibits robust anti-inflammatory activity in vivo and highlights the therapeutic potential of designed multitarget agents.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Tosyl Compounds
/
Drug Design
/
Anti-Inflammatory Agents, Non-Steroidal
/
Polypharmacology
Limits:
Animals
/
Humans
Language:
En
Journal:
J Med Chem
Journal subject:
QUIMICA
Year:
2018
Document type:
Article
Affiliation country:
Germany